iTRAQ-based high-throughput proteomics analysis reveals alterations of plasma proteins in patients infected with

Junmei Bian1, Min Liang1, Shuxian Ding1

  • 1Tongren Hospital of Wuhan University (Wuhan Third Hospital), Wuhan, PR China.

Plos One
|November 22, 2019
PubMed

Insights

Human bocavirus (HBoV) causes acute respiratory tract infections in children. This study identified 293 differentially expressed proteins in HBoV-infected patients, revealing key pathways involved in the disease

Area of Science:

  • Virology
  • Proteomics
  • Bioinformatics

Background:

  • Human bocavirus (HBoV) is a significant cause of acute respiratory tract infections (ARTI) in children.
  • While HBoV's clinical impact is known, the molecular mechanisms of its pathogenesis remain unclear.

Purpose of the Study:

  • To investigate the proteomic profile of HBoV-infected individuals with ARTI.
  • To identify differentially expressed proteins (DEPs) and elucidate molecular pathways involved in HBoV pathogenesis.

Main Methods:

  • Proteomic analysis of plasma samples from ARTI cases and healthy controls using isobaric tags for relative and absolute quantitation (iTRAQ).
  • Bioinformatic analyses including Gene Ontology (GO), Cluster of Orthologous Groups (COG), and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment.
  • Validation of candidate protein expression using western blotting.

Main Results:

  • Identified 293 DEPs between ARTI cases and healthy controls (148 upregulated, 135 downregulated).
  • Enrichment analysis revealed involvement of complement activation, immunity, inflammation, signal transduction, and metabolism.
  • KEGG analysis highlighted pathways such as Wnt signaling, PPAR signaling, and complement and coagulation cascades.

Conclusions:

  • This is the first iTRAQ-based proteomic study of HBoV-infected ARTI cases.
  • The findings provide a foundation for understanding the molecular pathogenesis of HBoV infection in children.
  • Identified DEPs and pathways offer potential targets for future research and therapeutic strategies.